Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc., is a biopharmaceutical company developing and delivering innovative therapies in critical care and infectious disease.  Our approved treatments are indicated for use in life-threatening circumstances for seriously ill patients, and our investigational therapies are in development for patients fighting drug-resistant pathogens.

Growing antimicrobial resistance to existing therapies represents an urgent threat to global public health, and is directly related to significant mortality rates and longer, more expensive hospital stays. We are proud to work with physicians, nurses, hospital pharmacists and administrators, and all who devote their time to caring for patients. 

Biotechnology

Health Care

Therapeutics

Innoviva Specialty Therapeutics, Inc.

Steve Basso

David Altarac

Marianne Zhen

Marcie Cain

The Medical Affairs Team at Innoviva Specialty Therapeutics, Inc. is responsible for providing scientific and clinical support for our therapies, engaging with healthcare professionals to disseminate critical information, and ensuring the safe and effective utilization of our products. They contribute to the strategic planning of clinical development programs, support regulatory submissions, and collaborate with medical and scientific communities to address unmet medical needs related to critical care and infectious disease.

Medical Affairs Team

Director Team

Clinical Operations & Development

Critical Care Team

Medical Affairs Team

About

Team members

Other teams at Innoviva Specialty Therapeutics, Inc.

Director Team

Clinical Operations & Development

Critical Care Team